{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:03Z","timestamp":1761513243704,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.3816\/clm.2001.n.003","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:09:53Z","timestamp":1221080993000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma"],"prefix":"10.3816","volume":"1","author":[{"given":"Diane D.","family":"Wilder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2001.n.003_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non- Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2001.n.003_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00001622-199210000-00007","article-title":"Prognostic factors in non-Hodgkin's lymphoma","volume":"4","author":"Shipp","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.1995.13.7.1734","article-title":"Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP","volume":"13","author":"Rodriguez","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","article-title":"ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year followup study","volume":"12","author":"Velasquez","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.3816\/CLM.2001.n.003_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10428199709058327","article-title":"The role of MDR-1 in refractory lymphoma","volume":"28","author":"Sandor","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2001.n.003_bib7","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.1994.12.11.2453","article-title":"Multidrug resistance in lymphomas","volume":"12","author":"Yuen","year":"1994","journal-title":"J Clin Oncol"},{"issue":"suppl 5","key":"10.3816\/CLM.2001.n.003_bib8","first-page":"20","article-title":"Non-P-glycoprotein drug export mechanisms of multidrug resistance","volume":"34","author":"List","year":"1997","journal-title":"Semin Hematol"},{"issue":"suppl 3","key":"10.3816\/CLM.2001.n.003_bib9","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1007\/BF02351068","article-title":"Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas","volume":"121","author":"Wilson","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib10","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1182\/blood.V89.10.3795","article-title":"Expression of the multidrug resistance- associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay","volume":"89","author":"Zhan","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2001.n.003_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1200\/JCO.1993.11.1.109","article-title":"Expression of P-glycoprotein and glutathione- S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors","volume":"11","author":"Cheng","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.2910490512","article-title":"P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines","volume":"49","author":"Lai","year":"1991","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2001.n.003_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1200\/JCO.1993.11.8.1573","article-title":"EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma","volume":"11","author":"Wilson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib14","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1200\/JCO.2000.18.21.3633","article-title":"Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: An 8-year followup study of EPOCH","volume":"18","author":"Gutierrez","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ajhp\/56.10.985","article-title":"Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection","volume":"56","author":"Wolfe","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.3816\/CLM.2001.n.003_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.annonc.a058364","article-title":"E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma","volume":"4","author":"Johnson","year":"1993","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2001.n.003_bib18","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy- sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:11:02Z","timestamp":1761513062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511701749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S1526965511701749"],"URL":"https:\/\/doi.org\/10.3816\/clm.2001.n.003","relation":{},"ISSN":["1526-9655"],"issn-type":[{"type":"print","value":"1526-9655"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLM.2001.n.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}